Extracorporeal CO2 Removal Devices

Extracorporeal CO2 Removal Devices

Global Extracorporeal CO2 Removal Devices Market to Reach US$151.9 Million by 2030

The global market for Extracorporeal CO2 Removal Devices estimated at US$101.4 Million in the year 2023, is expected to reach US$151.9 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$27.4 Million While China is Forecast to Grow at 5.5% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$27.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$23.6 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Extracorporeal CO2 Removal Devices Market - Key Trends & Drivers Summarized

Why Are Extracorporeal CO2 Removal Devices Critical for Respiratory Care?

Extracorporeal CO2 removal (ECCO2R) devices have become vital in the management of severe respiratory conditions, offering a less invasive alternative to traditional ventilation. ECCO2R devices function by removing carbon dioxide (CO2) from the patient’s blood externally, providing relief for patients with chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and other lung disorders where CO2 accumulation is a critical concern. These devices are particularly beneficial in managing severe cases without the need for high-pressure mechanical ventilation, which can cause further lung injury. By reducing CO2 levels, ECCO2R devices help stabilize respiratory functions, allowing the lungs to rest and recover. The development of portable and user-friendly versions of these devices is also expanding their use beyond intensive care units, making them a promising solution for chronic respiratory management.

How Are Technological Advancements Shaping the ECCO2R Market?

With continuous advancements in medical technology, ECCO2R devices are becoming more efficient, compact, and adaptable to various patient needs. Innovations include integrating biocompatible materials that minimize complications and infections, and the use of advanced monitoring systems that ensure precise CO2 removal tailored to each patient’s specific condition. The trend toward minimally invasive approaches in healthcare has also led to the design of ECCO2R devices that are less intrusive, enabling quicker setup and easier integration into existing respiratory support systems. Additionally, companies are focusing on developing portable devices that offer greater flexibility for both in-hospital and home care settings, opening new avenues for chronic condition management. These advancements are making ECCO2R devices a pivotal component in the management of respiratory diseases, enhancing patient outcomes while reducing healthcare costs.

What Are the Emerging Applications and Trends in ECCO2R Devices?

The market for ECCO2R devices is expanding as their applications extend beyond traditional hospital settings. With increasing incidences of chronic respiratory diseases globally, these devices are now being explored for long-term management solutions, especially in outpatient and home-care environments. Medical practitioners are increasingly adopting ECCO2R devices for critical care scenarios where traditional methods might be ineffective or pose risks of complications. Furthermore, the COVID-19 pandemic has highlighted the need for effective respiratory support devices, boosting the research and development efforts towards improving ECCO2R efficiency and accessibility. The growing emphasis on patient mobility and comfort is also pushing manufacturers to innovate, producing lighter and more versatile devices that can be used in diverse care settings, including emergency response units and field hospitals.

What Factors Are Fueling the Growth of the ECCO2R Market?

The growth in the ECCO2R market is driven by several factors, including the increasing prevalence of respiratory diseases such as COPD and ARDS, which demand effective CO2 management solutions. The impact of the COVID-19 pandemic has also underscored the necessity for advanced respiratory support technologies, further stimulating demand. Additionally, technological innovations, such as the development of biocompatible and minimally invasive ECCO2R devices, are enhancing the adoption of these systems in various healthcare settings. The push towards portable and home-care respiratory solutions, fueled by patient preference and the need for healthcare cost reduction, is further accelerating the market’s growth. Rising investments in healthcare infrastructure and respiratory device innovation, particularly in emerging markets, are expected to create significant growth opportunities in the ECCO2R sector.

Select Competitors (Total 44 Featured) -
  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Extracorporeal CO2 Removal Devices – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Respiratory Disorders Fueling Demand for CO2 Removal
Growing Adoption of Minimally Invasive Respiratory Support Technologies
Expansion of Intensive Care Units and Demand for Advanced Respiratory Equipment
Increasing Focus on Reducing Ventilator Dependency in Critical Care
Technological Advancements in Extracorporeal Life Support Systems
Rising Demand for Portable and User-Friendly CO2 Removal Devices
Growth in Awareness of Lung Preservation and Respiratory Support Options
Increased Research and Development for Efficient Gas Exchange Technologies
Growing Investment in Respiratory Care in Hospitals and Clinics
Surge in Use of CO2 Removal in Emergency and Acute Care Settings
Expansion of Extracorporeal Therapies in Cardiopulmonary Rehabilitation
Rising Demand for CO2 Removal in Pediatric and Neonatal Care
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Extracorporeal CO2 Removal Devices Market Analysis of Annual Sales in US$ for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Extracorporeal CO2 Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Venovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Arteriovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Bridge To Lung Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 43: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 44: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 48: USA Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 49: USA 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 51: USA Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 52: USA 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 54: USA Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 55: USA 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 58: Canada 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 61: Canada 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 64: Canada 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 65: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 66: Canada Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 67: Canada 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 68: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 70: Japan 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 73: Japan 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 75: Japan Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 76: Japan 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 77: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 78: Japan Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 79: Japan 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 80: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 81: China Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 82: China 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 84: China Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 85: China 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 87: China Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 88: China 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 89: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 90: China Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 91: China 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 92: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 94: Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 96: Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 97: Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 99: Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 100: Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 102: Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 103: Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 104: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 105: Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 106: Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 107: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 108: France Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 109: France 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 111: France Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 112: France 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 114: France Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 115: France 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 116: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 117: France Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 118: France 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 119: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 120: Germany Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 121: Germany 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 123: Germany Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 124: Germany 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 126: Germany Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 127: Germany 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 128: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 129: Germany Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 130: Germany 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 131: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 132: Italy Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 133: Italy 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 135: Italy Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 136: Italy 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 138: Italy Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 139: Italy 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 140: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 141: Italy Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 142: Italy 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 143: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 144: UK Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 145: UK 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 147: UK Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 148: UK 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 150: UK Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 151: UK 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 152: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 153: UK Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 154: UK 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 165: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 166: Rest of Europe 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 169: Asia-Pacific 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 171: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 172: Asia-Pacific 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 174: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 175: Asia-Pacific 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 177: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 178: Asia-Pacific 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 179: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of World 16-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2014, 2024 & 2030
TABLE 182: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of World 16-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2014, 2024 & 2030
TABLE 185: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of World 16-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2014, 2024 & 2030
TABLE 188: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of World 16-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings